Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Company has officially moved its global headquarters to Northridge, California, in a 40,000 sq. ft. building in the heart of the San Fernando Valley
By: Betsy Louda
HemaCare Corporation, a company working in customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, has officially moved its global headquarters to Northridge, California. The new facility allows HemaCare to more than double its donor collection capacity and on-site cell processing capabilities. Located at the 44-acre Harman Campus, in the heart of the San Fernando Valley, the 40,000-square-foot newly renovated facility reflects the company’s accelerated growth. The cell therapy industry continues to see a rapid increase in demand for high-quality starting material. HemaCare has become the number one most trusted supplier of human biological material for cell therapy customers around the world. This trust was earned by consistently maintaining the highest quality standards, a consultative approach, and customization to meet unique process development needs. “Los Angeles is the perfect place for businesses to find talented workers and an atmosphere of growth and innovation,” said Mayor Eric Garcetti. “HemaCare was recognized by the LA Business Journal as one of the 100 fastest growing companies in our county, and we are thrilled that it is expanding to The Mix at Harman Campus in Northridge.” With four GMP clean rooms, the facility has been designed to accommodate HemaCare’s specialized cell collection and processing equipment to support clinical and commercial drug development. HemaCare’s on-site GMP facility processing capabilities include cell collection, cell washing and isolation/separation, controlled-rate freezing for cryopreservation, and biorepository services for controlled storage. Adding expanded GMP capabilities to HemaCare’s industry-leading knowledge and experience will further propel their ability to partner with regenerative medicine and cell therapy companies. HemaCare’s new state-of-the-art facility is expertly designed to enable a seamless transition from donor recruitment and collection to the downstream processing, storage, and subsequent transport of the cell therapy starting materials. The additional space positions HemaCare for scalability and significantly increased technical capabilities necessary to meet the rapidly growing number of requests for high-quality, consistent cell therapy starting material. “Our new headquarters reflects HemaCare’s mission to continue to supply the best-in-class portfolio of high-quality, customizable human cellular material and services to the scientific research and cell therapy industries,” said Pete van der Wal, president and chief executive officer of HemaCare. “It also demonstrates HemaCare’s commitment to equip our current and future employees with the workspace environment and state-of-the-art tools they need to flourish.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !